In RCC, 70% and 12% of patients with metastatic RCC and localized RCC showed serum GGT > 60 U/L, respectively, indicating the sensitivity of serum GGT as a marker for predicting the presence of a metastasis [80]. Here, GGT1 is linked to renal cell carcinoma.